Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Fabio Chianelli
Recent news which mentions Fabio Chianelli
Ketamine Could Soon Be A Treatment Option For This Rare Genetic Neurological Disorder
November 01, 2022
Tickers
PHRRF
Tags
Neurological Disorders
Psychedelics
Benzinga
From
Benzinga
Ketamine for Parkinson's Disease, PharmaTher Holdings Announces Grant of U.S. Patent To Cover It
October 05, 2022
Tickers
PHRRF
Tags
News
Penny Stocks
Market News
From
Benzinga
PharmaTher Provides Business Highlights And Releases Audited Annual Financials
September 29, 2022
Tickers
PHRRF
Tags
Markets
Fabio Chianelli
Cannabis
From
Benzinga
PharmaTher Presents Positive Data On Ketamine For Treatment Of Dyskinesia In Parkinson's Disease
September 17, 2022
Tickers
PHRRF
Tags
Market News
Fabio Chianelli
Cannabis
From
Benzinga
Intradermal Ketamine Patch Completes Pre-Clinical Phase, Advances To Clinical Studies
September 07, 2022
Tickers
PHRRF
Tags
News
Fabio Chianelli
Cannabis
From
Benzinga
PharmaTher Receives Notice Of Allowance For U.S. Patent Covering Ketamine For Parkinson's And Motor Disorders Treatment
July 13, 2022
Tickers
PHRRF
Tags
Markets
Market News
University of Arizona
From
Benzinga
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
October 18, 2021
Tickers
AGNPF
ALID
ATAI
AWKNF
Tags
PSYBF
CMPS
LKYSF
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.